Drawing for SPARKOVI

USPTO serial 90072537

SPARKOVI

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
NKOJO, RHODA K
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPARKOVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jared M. Barrett

Jared M. Barrett SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport SyndromeABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2021MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Feb 1, 2021ABN5ABANDONMENT - AFTER PUBLICATION—
Feb 1, 2021ISPOWITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST—
Jan 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 6, 2021EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jan 5, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 5, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 5, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 23, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2020GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 16, 2020GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 16, 2020CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 10, 2020DOCKASSIGNED TO EXAMINER—
Aug 24, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance